B Riley FBR

Broadcom Inc (NASDAQ: AVGO) moved 15 percent lower Thursday on mixed reactions following the announcement it had reached a deal to acquire CA, Inc. (NASDAQ: CA). CA Inc. (also known as CA Technologies) jumped 18 percent higher, realizing most of the 20 percent premium to the July 11 closing price...

Arbutus Biopharma Corp (NASDAQ: ABUS) stock has gained 80 percent since the turn of the year, and B. Riley FBR dropped its bullish stance Friday in the wake of the rally.   The Analyst B. Riley FBR's Madhu Kumar downgraded Arbutus Biopharma from Buy to Neutral with an unchanged $...

Nano-cap pharma company Alimera Sciences Inc (NASDAQ: ALIM) could nearly triple in value for three key reasons, according to B. Riley FBR.  The Analyst Analyst Andrew D'Silva initiated coverage of Alimera Sciences with a Buy rating and $2.75 price target. The Thesis Alimera is a...

Uniqure NV (NASDAQ: QURE), a gene therapy company that focuses on severe unmet medical needs, could "dominate" the space with its AMT-061 therapy, according to B. Riley FBR. The Analyst B. Riley FBR's Madhu Kumar initiated coverage of Uniqure with a Buy rating and $50 price target....

Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) lost a sell-side bull Tuesday, with a B. Riley FBR analyst praising the company's pipeline but concluding the biotech's positives are priced into the stock. The Analyst B. Riley FBR's Madhu Kumar downgraded Deciphera from Buy to Neutral. The...

A tough mortgage banking environment will likely lead to cost savings initiatives from HomeStreet Inc (NASDAQ: HMST), which should result in an improved 2019 earnings outlook, according to B. Riley FBR. The Analyst Steve Moss of B. Riley FBR upgraded HomeStreet shares from Neutral to Buy and...

Shares of Ramaco Resources Inc (NASDAQ: METC), a developer of metallurgical coal, have about 24-percent upside potential that's contingent on continued execution by the company, according to B. Riley FBR.  The Analyst Analyst Lucas Pipes initiated coverage of Ramaco with a Buy rating...

Large-cap tech names posted strong quarterly results this earnings season, and Intel Corporation (NASDAQ: INTC) was no exception. The chip giant reported 13-percent revenue growth and a 32-percent increase in non-GAAP earnings per share Thursday; the company also raised its full-year revenue and...

An optimistic trial outlook on Clementia Therapeutics, Inc. (NASDAQ: CMTA)’s palovarotene in FOP patients could give the pharmaceutical company a leg up in an unmet market for the treatment of a rare disease, according to B. Riley FBR. The Analyst Madhu Kumar of B. Riley FBR initiated...

Dicerna Pharmaceuticals Inc (NASDAQ: DRNA), a biotechnology company developing GalXC RNAi platforms for various diseases, has seen its stock soar 140 percent over the past six months. But a combination of good news and bad news should leave investors on the sidelines, according to B. Riley FBR....

NVIDIA Corporation (NASDAQ: NVDA) investors didn’t seem to get what they were hoping for at the tech company's analyst day Tuesday. The stock is now down more than 10 percent in the past two days. Here’s a sampling of what analysts had to say about Nvidia after the company'...

Main Street Capital Corporation (NYSE: MAIN) has materially grown its net asset value and dividend, resulting in a higher return relative to all other business development company peers, according to B Riley FBR.  The Analyst Analyst Tim Hayes initiated coverage of Main Street Capital...

After several months of speculation, Finish Line Inc (NASDAQ: FINL) announced it has been acquired by a U.K. retailer, but not the one that was previously named. JD Sports, known as one of the premier footwear retailers in the U.K., has purchased the Indianapolis-based footwear retailer for $588...

BB&T Corporation (NYSE: BBT) shares pulled back along with the broader market last week, although they have recouped part of their losses since then. The Analyst B Riley FBR analyst Steve Moss upgraded shares of BB&T from Neutral to Buy and increased the price target from $55 to $69,...